Name: 글로벌 시장 동향
SKU: MDP858
Availability: InStock

보고서 요약(국문)

수혈 진단 시장 규모
세계 수혈 진단 시장은 2023년 24억 9천만 달러에 달했으며, 2024년부터 2031년까지 연평균 5.7%의 성장률을 보이며 2031년에는 38억 4천만 달러에 이를 것으로 예상됩니다.
수혈 진단 시장 동향
혈액암, 심각한 부상 및 사고 발생률 증가로 인해 이러한 진단 제품에 대한 수요가 증가하고 있습니다. 수술 건수 증가, 연구 개발 투자 증가, 신제품 출시 증가 등이 시장 성장을 견인할 것으로 예상됩니다.
신제품 출시 증가와 심각한 부상 및 사고 사례 증가는 시장 성장을 촉진할 것입니다.
세계 수혈 진단 시장은 혈액암, 빈혈, 겸상 적혈구 빈혈, 신장 질환 및 수혈 매개 감염과 같은 심각한 감염을 포함한 만성 질환 증가로 인한 의료 산업의 진단 제품 수요에 의해 주로 주도됩니다. 사고, 외상 및 고통스러운 수술 건수 증가는 시장 성장을 촉진하는 요인입니다. 예를 들어, 2022년 8월 QuidelOrtho Corporation은 자회사인 체외 진단 서비스 제공업체 Ortho Clinical이 개발한 Ortho 워크스테이션에 대해 AABB "표준 준수" 품질 인증을 획득했다고 발표했습니다. 이 워크스테이션은 배양기와 원심분리기를 결합한 2-in-1 기능을 갖춘 혈액 검사 시스템입니다.
다양한 투자 유치, 혁신적인 기술 발전, 그리고 최신 혁신 제품 출시가 증가함에 따라 수혈 진단에 대한 수요가 높아지고 있습니다. 예를 들어, 2022년 7월 Roche는 단일 인체 샘플로 C형 간염 바이러스 항체와 항원 상태를 독립적으로 검출할 수 있는 최초의 면역 분석법인 Elecsys HCV Duo 면역 분석법을 출시했습니다. 이 검사는 감염 초기 단계에 감염을 감지할 수 있으며, 환자의 회복기 또는 만성 감염 증상이 나타날 때 사용할 수 있습니다.
하지만 수혈 진단과 관련된 높은 비용은 시장 성장을 저해하는 요인이 될 것입니다.

하지만 수혈 진단용 품질 보증 키트 및 기기의 높은 보급률은 성장을 저해하는 주요 요인입니다. 숙련된 전문가 부족으로 자동화 기기를 다루고 정확한 결과를 도출하는 데 어려움이 있습니다.
COVID-19 영향 분석
코로나19 팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. 특히 의료 산업은 심각한 타격을 입었습니다. 모든 헌혈 행사가 취소되면서 수혈 진단 시장은 막대한 손실을 입었습니다. 사람들은 코로나19 확산과 수혈로 인한 감염 위험 때문에 수혈을 꺼렸습니다. 그러나 이제 시장 참여자들은 연구 시장을 활용하고 팬데믹에 대응하기 위한 최첨단 제품을 개발함으로써 장단기 성장 전략을 수정하고 있습니다. 전 세계적으로 다양한 계획, 협력 및 인수합병이 진행되면서 시장 성장을 촉진하고 있습니다. 예를 들어, 체외 진단 혁신 기술 제공업체인 QuidelOrtho Corp는 2022년 8월 혈액 공급 강화를 위해 혈액 및 생물치료 발전 협회(Association for Advancement of Blood and Biotherapies)가 설립한 연합체인 Alliance에 가입한다고 발표했습니다.

수혈 진단 시장 세분화 분석
질병 선별 검사 부문은 예측 기간(2024-2031년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
질병 선별 검사 부문은 전 세계 수혈 진단 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 기증된 모든 혈액은 임상 용도로 사용하기 전에 혈액 내 감염 여부를 확인하기 위해 검사되는데, 이를 질병 선별 검사라고 합니다. 바이러스 특이 항원 및 항체를 표적으로 하는 혈청학적 검사법의 도입은 수혈 전염성 감염병(TTI), HIV, B형 간염 바이러스, C형 간염 바이러스와 같은 수혈 전염성 병원체 등 기증 혈액의 감염 여부를 감지하는 데 매우 유용합니다. 최신 핵산 증폭 기술 선별 검사는 감염 위험을 효과적으로 최소화합니다.
질병 선별 검사 부문이 시장을 주도하는 이유는 전 세계적으로 혈액암 발병 사례가 증가하고 있기 때문입니다. 세계보건기구(WHO)에 따르면 2022년 전 세계적으로 매년 약 124만 건의 혈액암 사례가 발생했습니다. 혈액 관련 질환 환자 수 증가, 규제 승인, 기술 발전 및 연구/임상 시험 연구의 성장이 시장 성장을 견인하고 있습니다. 예를 들어, 2022년 6월 혈장 유래 치료 및 혁신적인 진단 솔루션 개발업체인 그리폴스(Grifols)는 말라리아 관련 환자의 헌혈자를 위해 특별히 설계된 최초의 자동 핵산 검사 시스템인 프로클레이스 플라스모디움 어세이(Procleix Plasmodium Assay)에 대해 CE 마크를 획득했다고 발표했습니다.
수혈 진단 시장 지역별 점유율
북미 지역은 전 세계 수혈 진단 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미가 전 세계 수혈 진단 시장을 주도하는 주요 요인은 전 세계적인 환경 변화로 인한 혈액암, 빈혈, 혈우병, 신장 질환 등 만성 질환의 유병률 증가, 잘 구축된 의료 인프라, 그리고 연구 개발 활동에 대한 높은 투자입니다. 또한, 광범위한 환자 기반도 시장 점유율 성장에 기여하고 있습니다. 세계보건기구(WHO)에 따르면 2022년 전 세계적으로 200만 명 이상이 빈혈을 앓게 될 것으로 예상되며, 이는 전 세계 인구의 약 25%에 해당합니다.
또한, 제품 출시 증가가 시장 성장의 주요 요인입니다. GDP 대비 의료비 지출 증가와 같은 다른 요인들도 시장 성장을 촉진하고 있습니다. 이 지역에서는 많은 주요 개발, 기술 발전, 협력 및 계약이 활발히 진행되고 있습니다. 예를 들어, 2022년 9월 혈장 의약품 제조업체인 그리폴스(Grifols)는 캐나다 국립 혈액 관리 기관인 캐나다 혈액 서비스(Canadian Blood Services)와 필수 혈장 단백질 치료제 및 면역글로불린 의약품의 자급률을 높이기 위한 계약을 발표했습니다.
수혈 진단 시장 기업 및 경쟁 환경
수혈 진단 시장은 국내외 기업들의 존재로 인해 경쟁이 매우 치열합니다. Ortho Clinical Diagnostics, Beckman Coulter, Quotient Limited, Abbott Laboratories, Diagast, Becton, Dickinson & Company, Immucor Inc., Grifols S.A., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd. 등 여러 주요 기업들이 제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 5월 Quidel Corporation은 Ortho Clinical Diagnostics Holdings와 합병하여 체외 진단 제품 및 서비스 제공업체인 QuidelOrtho Corporation을 설립하는 거래를 완료했다고 발표했습니다.
Ortho Clinical Diagnostics:
개요:
Ortho Clinical Diagnostics는 혈액형 검사를 위한 체외 진단 장비를 제공하는 회사입니다. 자동 및 반자동 검사 제품과 검사 메뉴 제품을 생산합니다. 1939년에 설립되었으며 미국 뉴저지에 본사를 두고 있습니다.

제품 포트폴리오:
오쏘 비전 플랫폼: 이 플랫폼은 수혈 시 환자가 올바른 혈액형을 수혈받도록 혈액 적합성을 검사하는 분석기로 구성됩니다. 오쏘 비전 제품은 대용량 검사실에 적합하게 설계되어 연속 희석, 특정 세포 항체 식별 및 반사 검사를 포함한 복잡한 면역혈액학 검사를 수행할 수 있습니다.
주요 개발: 2021년 9월, 체외 진단 기업인 오쏘 클리니컬 다이애그노스틱스는 수혈 시 수혈자와 기증자 간의 혈액형 부적합성을 판별하는 데 도움을 주는 즉시 스핀 교차매칭(ISXM)을 출시한다고 발표했습니다. 이 혈청학적 검사는 수혈자의 혈장과 기증자의 적혈구 간의 ABO 혈액형 부적합성을 판별합니다.
글로벌 수혈 진단 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Transfusion Diagnostics Market Size
The Global Transfusion Diagnostics Market reached US$ 2.49 billion in 2023 and is expected to reach US$ 3.84 billion by 2031, growing at a CAGR of 5.7% during the forecast period 2024-2031.
Transfusion Diagnostics Market Dynamics
The increasing demand for these diagnostic products is due to the rising incidence of blood cancer, serious injuries, and accidents. The rising number of surgeries, increasing research and development expenditure and growth in novel product launches are expected to drive market growth.
The increasing novel product launches and rising number of serious injuries and accident cases will drive market growth.
The global market for transfusion diagnostics is primarily driven by the healthcare industry's demand for diagnostic products due to increasing chronic illnesses, including blood cancer, anemia, sickle cell anemia, kidney disease and serious infection such as transfusion-transmitted infections. The rising number of accidents, trauma and painful surgeries drive the market’s growth. For instance, in Aug 2022, QuidelOrtho Corporation announced receiving AABB “standards compliant” designation quality seal for an Ortho workstation developed by its subsidiary, Ortho Clinical, in vitro diagnostic services provider. This workstation is a blood testing system that has a 2-in-1 feature as it combines an incubator and a centrifuge.
Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for these transfusion diagnostics. For instance, in July 2022, Roche launched Elecsys HCV Duo immunoassay, the first immunoassay that permits independent detection of hepatitis C virus antibodies and antigen status by a single human sample. This test can detect the infection at an early stage and can be used during the patient’s recovery phase or when showing chronic infection symptoms.
The high costs associated with transfusion diagnostics will hamper the market’s growth.
However, high rates of quality-assured kits and instruments for transfusion diagnostics are the major factor restraining the growth. The unavailability of experienced professionals makes it difficult to handle the automated instruments and provide accurate results.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The transfusion diagnostics market has experienced huge losses due to COVID, as all the blood drives were canceled. People refused to get transfusions because of the spread of COVID and transfusion-transmitted infections. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in Aug 2022, QuidelOrtho Corp, in vitro diagnostic innovative technology provider, announced joining the Alliance, a coalition established by the Association for Advancement of Blood and Biotherapies to strengthen the blood supply.
Transfusion Diagnostics Market Segmentation Analysis
The disease screening segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)
The disease screening segment is the highest market holder in the global transfusion diagnostics market. All the blood donated is screened to get evidence of the absence of any infection in the blood before releasing the blood and its components for clinical use, which is known as disease screening. Introducing serological assays that target virus-specific antigens and antibodies is very useful for detecting infection in donated blood, such as transfusion-transmitted infectious agents like TTIs, HIV, hepatitis B virus and hepatitis C virus. The latest nucleic acid amplification technology screening effectively minimizes the risk of infection.
Disease screening dominates the market due to increased blood cancer cases globally. According to the World Health Organization, in 2022, approximately 1.24 million blood cancer cases occur globally annually. The rising number of people suffering from blood-related disorders, regulatory approvals and growing technological advancements or research/clinical trial studies drive the market’s growth. For Instance, in Jun 2022, Grifols, plasma-derived therapy and innovative diagnostic solutions developer, announced receiving the CE mark for Procleix Plasmodium Assay, 1st automatic nucleic acid test system specially designed for blood donors for patients related to malaria.
Transfusion Diagnostics Market Geographical Share
North America region holds the largest market share of the global transfusion diagnostics market.
North America dominates the global transfusion diagnostics market, primarily attributed to the rising prevalence of chronic ailments such as blood cancer, anemia, hemophilia, kidney disease and many more due to changing environments worldwide, established healthcare infrastructure, and higher investment in R&D activities contribute to North America’s rapid share growth. Moreover, its broad base patient population also contributes to the growth of its share. According to the World Health Organization, in 2022, more than 2 million people will suffer from anemia globally, affecting around 25% of the world’s population.
Moreover, the growing number of product launches is responsible for the market’s growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market’s growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Sep 2022, Grifols, a plasma medicine manufacturer, announced its agreement with Canada’s national blood authority, Canadian Blood Services, to expand its self-sufficiency in essential plasma protein therapies and immunoglobulin medicines.
Transfusion Diagnostics Market Companies and Competitive Landscape
The transfusion diagnostics market is highly competitive with local and global companies’ presence. Ortho Clinical Diagnostics, Beckman Coulter, Quotient Limited, Abbott Laboratories, Diagast, Becton, Dickinson & Company, Immucor Inc., Grifols S.A., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in May 2022, Quidel Corporation announced transaction completion to combine with Ortho Clinical Diagnostics Holdings to form QuidelOrtho Corporation, in vitro diagnostic products and services provider company.
Ortho Clinical Diagnostics:
Overview:
Ortho Clinical Diagnostics is a company that provides in vitro diagnostic equipment for blood typing. It produces automated and semiautomated testing products and testing menu products. It was established in 1939 and is headquartered in New Jersey, United States.
Product Portfolio:
Ortho Vision Platform: This platform comprises analyzers that test the compatibility of blood to make sure that patients receive the correct blood type during transfusion. Ortho vision products are designed for high-volume labs, allowing complex immunohematology testing, including serial dilutions, identifying particular cell antibodies and reflex tests.
Key Development: In Sep 2021, Ortho Clinical Diagnostics, an in vitro diagnostic company, announced the launch of Immediate Spin Crossmatch (ISXM) that will provide aid in determining the incompatibility during blood transfusion between the recipients and donors. This serological test determines the incompatibility of ABO blood type between the recipient plasma and donor RBCs.
The global transfusion diagnostics market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising novel product launches
4.1.1.2. Increasing demand for diagnostic transfusion products
4.1.2. Restraints:
4.1.2.1. High cost associated with diagnostic transfusion instruments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Unmet Needs
5.3. Supply chain Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments & Kits*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Reagents
7.4. Others
8. By Transfusion Types
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
8.1.2. Market Attractiveness Index, By Transfusion Types
8.2. Red Blood Cell Transfusion *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Platelet Transfusion
8.4. Plasma Transfusion
8.5. Whole Blood Transfusion
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Disease Screening *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Blood Typing
9.4. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Blood Banks*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Hospitals
10.4. Laboratories
10.5. Plasma Fractionation Facilities
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Transfusion Types
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch
13. Company Profiles
13.1. Ortho Clinical Diagnostics
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Beckman Coulter
13.3. Quotient Limited
13.4. Abbott Laboratories
13.5. Diagast
13.6. Becton, Dickinson & Company
13.7. Immucor Inc.
13.8. Grifols S.A.
13.9. Bio-Rad Laboratories
13.10. F. Hoffmann-La Roche Ltd.(*LIST NOT EXHAUSTIVE)
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

언급된 주요 기업들

Ortho Clinical Diagnostics, Beckman Coulter, Quotient Limited, Abbott Laboratories, Diagast, Becton, Dickinson & Company, Immucor Inc., Grifols S.A., Bio-Rad Laboratories

표 목록 (Tables)

List of Tables

Table 1 Global Transfusion Diagnostics Market Share, By Product Type, 2021, 2025 & 2029 (%)

Table 2 Global Transfusion Diagnostics Market Value, By Transfusion Types, 2021, 2025 & 2029 ($ Million)

Table 3 Global Transfusion Diagnostics Market Value, By Application, 2021, 2025 & 2029 ($ Million)

Table 4 Global Transfusion Diagnostics Market Value, By End-User, 2021, 2025 & 2029 ($ Million)

Table 5 Global Transfusion Diagnostics Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table 6 Global Transfusion Diagnostics Market Value, By Product Type, 2021, 2025 & 2029 ($ Million)

Table 7 Global Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 8 Global Transfusion Diagnostics Market Value, By Transfusion Types, 2021, 2025 & 2029 ($ Million)

Table 9 Global Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 10 Global Transfusion Diagnostics Market Value, By Application, 2021, 2025 & 2029 ($ Million)

Table 11 Global Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 12 Global Transfusion Diagnostics Market Value, By End-User, 2021, 2025 & 2029 ($ Million)

Table 13 Global Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 14 Global Transfusion Diagnostics Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table 15 Global Transfusion Diagnostics Market Value, By Region, 2020-2029 ($ Million)

Table 16 North America Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 17 North America Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 18 North America Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 19 North America Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 20 North America Transfusion Diagnostics Market Value, By Country, 2020-2029 ($ Million)

Table 21 South America Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 22 South America Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 23 South America Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 24 South America Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 25 South America Transfusion Diagnostics Market Value, By Country, 2020-2029 ($ Million)

Table 26 Europe Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 27 Europe Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 28 Europe Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 29 Europe Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 30 Europe Transfusion Diagnostics Market Value, By Country, 2020-2029 ($ Million)

Table 31 Asia-Pacific Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 32 Asia-Pacific Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 33 Asia-Pacific Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 34 Asia-Pacific Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 35 Asia-Pacific Transfusion Diagnostics Market Value, By Country, 2020-2029 ($ Million)

Table 36 Middle East & Africa Transfusion Diagnostics Market Value, By Product Type, 2020-2029 ($ Million)

Table 37 Middle East & Africa Transfusion Diagnostics Market Value, By Transfusion Types, 2020-2029 ($ Million)

Table 38 Middle East & Africa Transfusion Diagnostics Market Value, By Application, 2020-2029 ($ Million)

Table 39 Middle East & Africa Transfusion Diagnostics Market Value, By End-User, 2020-2029 ($ Million)

Table 40 Ortho Clinical Diagnostics: Overview

Table 41 Ortho Clinical Diagnostics: Product Portfolio

Table 42 Ortho Clinical Diagnostics: Key Developments

Table 43 Beckman Coulter: Overview

Table 44 Beckman Coulter: Product Portfolio

Table 45 Beckman Coulter: Key Developments

Table 46 Quotient Limited: Overview

Table 47 Quotient Limited: Product Portfolio

Table 48 Quotient Limited: Key Developments

Table 49 Abbott Laboratories: Overview

Table 50 Abbott Laboratories: Product Portfolio

Table 51 Abbott Laboratories: Key Developments

Table 52 Diagast: Overview

Table 53 Diagast: Product Portfolio

Table 54 Diagast: Key Developments

Table 55 Becton, Dickinson & Company: Overview

Table 56 Becton, Dickinson & Company: Product Portfolio

Table 57 Becton, Dickinson & Company: Key Developments

Table 58 Immucor Inc.: Overview

Table 59 Immucor Inc.: Product Portfolio

Table 60 Immucor Inc.: Key Developments

Table 61 Grifols S.A.: Overview

Table 62 Grifols S.A.: Product Portfolio

Table 63 Grifols S.A.: Key Developments

Table 64 Bio-Rad Laboratories: Overview

Table 65 Bio-Rad Laboratories: Product Portfolio

Table 66 Bio-Rad Laboratories: Key Developments

Table 67 F. Hoffmann-La Roche Ltd.: Overview

Table 68 F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 69 F. Hoffmann-La Roche Ltd.: Key Development

그림 목록 (Figures)

List of Figures

Figure 1 Global Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 2 Global Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 3 Global Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 4 Global Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 5 Global Transfusion Diagnostics Market Share, By Region, 2021 & 2029 (%)

Figure 6 Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 7 Global Transfusion Diagnostics Market Y-o-Y Growth, By Product Type, 2021-2029 (%)

Figure 8 Instruments & Kits: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 9 Reagents: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 10 Others: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 11 Global Transfusion Diagnostics Market Y-o-Y Growth, By Transfusion Types, 2021-2029 (%)

Figure 12 Red Blood Cell Transfusion: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 13 Platelet Transfusion: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 14 Plasma Transfusion: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 15 Whole Blood Transfusion: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 16 Global Transfusion Diagnostics Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 17 Disease Screening: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 18 Blood Grouping: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 19 Others: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 20 Global Transfusion Diagnostics Market Y-o-Y Growth, By End-User, 2021-2029 (%)

Figure 21 Blood Banks: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 22 Hospitals: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 23 Laboratories: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 24 Plasma Fractionation Facilities: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 25 Others: Global Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 26 Global Transfusion Diagnostics Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 27 North America Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 28 North America Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 29 North America Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 30 North America Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 31 North America Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 32 North America Transfusion Diagnostics Market Share, By Country, 2021 & 2029 (%)

Figure 33 South America Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 34 South America Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 35 South America Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 36 South America Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 37 South America Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 38 South America Transfusion Diagnostics Market Share, By Country, 2021 & 2029 (%)

Figure 39 Europe Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 40 Europe Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 41 Europe Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 42 Europe Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 43 Europe Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 44 Europe Transfusion Diagnostics Market Share, By Country, 2021 & 2029 (%)

Figure 45 Asia-Pacific Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 46 Asia-Pacific Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 47 Asia-Pacific Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 48 Asia-Pacific Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 49 Asia-Pacific Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 50 Asia-Pacific Transfusion Diagnostics Market Share, By Country, 2021 & 2029 (%)

Figure 51 Middle East & Africa Transfusion Diagnostics Market Value, 2020-2029 ($ Million)

Figure 52 Middle East & Africa Transfusion Diagnostics Market Share, By Product Type, 2021 & 2029 (%)

Figure 53 Middle East & Africa Transfusion Diagnostics Market Share, By Transfusion Types, 2021 & 2029 (%)

Figure 54 Middle East & Africa Transfusion Diagnostics Market Share, By Application, 2021 & 2029 (%)

Figure 55 Middle East & Africa Transfusion Diagnostics Market Share, By End-User, 2021 & 2029 (%)

Figure 56 Ortho Clinical Diagnostics: Financials

Figure 57 Beckman Coulter: Financials

Figure 58 Quotient Limited: Financials

Figure 59 Abbott Laboratories: Financials

Figure 60 Diagast: Financials

Figure 61 Becton, Dickinson & Company: Financials

Figure 62 Immucor Inc.: Financials

Figure 63 Grifols S.A.: Financials

Figure 64 Bio-Rad Laboratories: Financials

Figure 65 F. Hoffmann-La Roche Ltd.: Financials

글로벌 수혈 진단 시장 – 2024-2031

Global Transfusion Diagnostics Market - 2024-2031